31
Participants
Start Date
January 31, 2004
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
trastuzumab
Cycle 1 loading dose of 8 mg/kg, followed by 6 mg/kg every 3 weeks for subsequent cycles.
docetaxel
75 mg/m2 every three weeks, or 60 mg/m2 every three weeks depending on study findings
gefitinib
250 mg daily or 250 mg daily on days 2 through 14 depending on study findings
Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center, Long Beach
City of Hope Medical Group, Pasadena
Hematology Oncology Consultants-Hemet, Hemet
Tower Cancer Research Foundation, Beverly Hills
City of Hope Comprehensive Cancer Center, Duarte
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER